Kinsey G C, Murray M J, Swensen S J, Miles J M
Department of Nursing, Mayo Foundation, Rochester, MN.
Crit Care Med. 1994 Oct;22(10):1557-62.
To determine, using a sensitive glucose assay, whether monitoring of tracheal aspirate glucose concentration could serve as a marker of aspiration of enteral feedings.
Prospective, controlled trial.
Intensive care units of a tertiary care hospital.
Fifteen enterally fed and 15 nonenterally fed, tracheally intubated patients who had normal lung fields on a routine chest radiograph.
Patients with endotracheal tubes undergoing routine tracheal suctioning had tracheal secretions collected three times per day with a minimum of 4 hrs between samples for up to 5 days. Daily chest radiographs were reviewed for evidence of the development of pneumonitis using defined criteria.
Glucose concentrations in five commonly used commercial feeding formulas, as well as in the medications patients were receiving enterally or as an oral wash, were measured. Tracheal secretion glucose concentrations were 66 +/- 54 (SD) mg/dL (3.7 +/- 3.0 mmol/L) and 105 +/- 70 mg/dL (5.8 +/- 3.9 mmol/L) in the enterally fed and nonenterally fed patients, respectively (p = NS). Of the medications administered, the majority contained negligible glucose, but ten had > 3 mg/dose of glucose. However, there was no correlation between administration of these medications and the tracheal glucose concentrations. Tracheal glucose concentrations were similar in patients who received medications containing glucose and patients who received either no medications or medications with negligible glucose content. A small but significant correlation between blood glucose and tracheal secretion glucose concentrations (r2 = .15, p < .05) was observed. None of the patients developed aspiration pneumonitis. Glucose concentrations in widely used commercial formulas (44 to 202 mg/dL; 2.4 to 11.2 mmol/L) overlapped considerably with glucose concentrations in tracheal secretions in the absence of aspiration and were for the most part within 2 SD of mean values in tracheal secretions.
Tracheal secretions contain high glucose concentrations, both in enterally fed patients without evidence of aspiration pneumonitis and in nonenterally fed patients. The concentration of glucose in tracheal secretions appears to be determined, in part, by ambient extracellular glucose concentrations. We conclude that measurement of glucose in tracheal secretions is unlikely to be useful in monitoring for tube feeding aspiration in tracheally intubated, enterally fed patients.
采用灵敏的葡萄糖检测方法,确定监测气管吸出物葡萄糖浓度是否可作为肠内营养误吸的标志物。
前瞻性对照试验。
一家三级医院的重症监护病房。
15例接受肠内营养和15例未接受肠内营养的气管插管患者,其常规胸部X线片显示肺野正常。
接受气管插管并进行常规气管抽吸的患者,每天收集3次气管分泌物,样本采集间隔至少4小时,持续5天。每天复查胸部X线片,根据既定标准判断是否发生肺炎。
测量了5种常用商业喂养配方奶以及患者经肠内给予或用于口腔冲洗的药物中的葡萄糖浓度。接受肠内营养和未接受肠内营养的患者,气管分泌物葡萄糖浓度分别为66±54(标准差)mg/dL(3.7±3.0 mmol/L)和105±70 mg/dL(5.8±3.9 mmol/L)(p=无显著性差异)。在所使用的药物中,大多数药物的葡萄糖含量可忽略不计,但有10种药物每剂葡萄糖含量>3 mg。然而,这些药物的使用与气管葡萄糖浓度之间无相关性。接受含葡萄糖药物的患者与未接受任何药物或接受葡萄糖含量可忽略不计药物的患者,气管葡萄糖浓度相似。观察到血糖与气管分泌物葡萄糖浓度之间存在较小但显著的相关性(r2 = 0.15,p<0.05)。所有患者均未发生误吸性肺炎。在未发生误吸的情况下,广泛使用的商业配方奶中的葡萄糖浓度(44至202 mg/dL;2.4至11.2 mmol/L)与气管分泌物中的葡萄糖浓度有相当大的重叠,并且大部分在气管分泌物平均值的2个标准差范围内。
在无误吸性肺炎证据的接受肠内营养的患者和未接受肠内营养的患者中,气管分泌物均含有高浓度葡萄糖。气管分泌物中的葡萄糖浓度似乎部分由周围细胞外葡萄糖浓度决定。我们得出结论,对于气管插管且接受肠内营养的患者,测量气管分泌物中的葡萄糖不太可能用于监测管饲误吸。